Regulatory & Legal

With a new CEO, Menagerie Cellars is doubling down on its blend of luxury wine and conservation. Can this purpose-driven model scale in a tough market?

After a costly restatement process, Next Bridge Hydrocarbons shifts its drilling focus. But can a new strategy resolve its unique shareholder crisis?

Lucid Software’s ‘Awardable’ status on a key DoD marketplace signals a shift in how national security projects are planned, secured, and executed.

A regulatory filing uncovers a major bank's intricate derivatives strategy in a £2.3bn takeover, raising questions about market transparency.

A UK regulatory filing reveals a hedge fund's bet against Qualcomm, questioning its major takeover and highlighting the surprising global reach of financial oversight.

From a Greenland mine to a Romanian refinery, a tech breakthrough is de-risking a vital new source of rare earths for the West's defense and green tech.

A startup's breakthrough in GPS-denied warfare is redefining naval strategy and opening a new, complex frontier for strategic high-tech investment.

Amid rising geopolitical tensions, new US rare earth price assessments offer critical transparency. What does this mean for manufacturing and national security?

A new report finds 41% of firms have hired fraudulent candidates, exposing a critical gap between AI threats and outdated corporate defenses.

A $50M project brings high-speed fiber to 7,000 rural Virginia homes, showcasing a public-private blueprint for connecting underserved communities.

A startup's legal victory protects its revolutionary wound care tech derived from the axolotl, paving the way for a new era in regenerative medicine.

A new class of AI-driven blood tests can detect lung cancer recurrence years before imaging, shaking up patient care and the multi-billion dollar diagnostics market.

A potential $39M deal with Luminia positions NeoVolta to move from residential rooftops to utility-scale power, reshaping California's energy future.

Early results for INT230-6 show 50% fewer severe side effects, raising hopes for a treatment that could eliminate the toxic 'red devil' chemo.

Adagio Medical lands ex-Medtronic exec Sean Salmon. His mission: drive its novel cryoablation tech to disrupt the competitive cardiac arrhythmia market.

In the heart of oil country, a new boom is taking shape. New Era Energy & Digital is building a gigawatt-scale AI campus, but can it win the infrastructure race?

The return of a critical antibiotic after 14 years via a new, ultra-fast FDA pathway signals a major shift in U.S. industrial and health policy.

Biomerica's regulatory win in Egypt is more than a market entry; it's a strategic move to disrupt healthcare with low-cost, rapid diagnostic tools.

byNordic Acquisition Corp. buys another month in its search for a Nordic tech merger, but each extension drains funds and tests investor patience.

Praxis Precision Medicines secures a clear path to market for its rare epilepsy drug, blending genetic science with a savvy regulatory strategy.